Identification of a Novel Protein Synthesis Inhibitor Active against Gram‐Positive Bacteria
- 24 February 2012
- journal article
- research article
- Published by Wiley in ChemBioChem
- Vol. 13 (4) , 574-583
Abstract
In an effort to identify novel antibacterial chemotypes, we performed a whole‐cell screen for inhibitors ofStaphylococcus aureusgrowth and pursued those compounds with previously uncharacterized antibacterial activity. This process resulted in the identification of a benzothiazolium salt, ABTZ‐1, that displayed potent antibacterial activity against Gram‐positive pathogens. Several clinically desirable qualities were demonstrated for ABTZ‐1 including potent activity against multidrug‐resistant clinical isolates of methicillin‐resistantS. aureus(MRSA) and vancomycin‐resistant enterococci (VRE), retention of this activity in human serum, and low hemolytic activity. The antibacterial activity of ABTZ‐1 was attributed to its inhibition of bacterial translation, as this compound prevented the incorporation of [35S]methionine intoS. aureusproteins, and ABTZ‐1‐resistant strains were cross‐resistant to known inhibitors of bacterial translation. ABTZ‐1 represents a promising new class of antibacterial agents.Keywords
This publication has 37 references indexed in Scilit:
- Chemical genomics in Escherichia coli identifies an inhibitor of bacterial lipoprotein targetingNature Chemical Biology, 2009
- Antibiotics for Emerging PathogensScience, 2009
- Genetic Determinants of Resistance to Fusidic Acid among Clinical Bacteremia Isolates of Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2009
- Toxin–antitoxin systems are ubiquitous and plasmid-encoded in vancomycin-resistant enterococciProceedings of the National Academy of Sciences, 2007
- Identification of novel antimicrobials using a live-animal infection modelProceedings of the National Academy of Sciences, 2006
- Iron Salts Perturb Biofilm Formation and Disrupt Existing Biofilms of Pseudomonas aeruginosaChemistry & Biology, 2005
- National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004American Journal of Infection Control, 2004
- Antibacterials: are the new entries enough to deal with the emerging resistance problems?Current Opinion in Biotechnology, 2003
- Resistance to Quinupristin-Dalfopristin Due to Mutation of L22 Ribosomal Protein inStaphylococcus aureusAntimicrobial Agents and Chemotherapy, 2002
- Oxazolidinones, a new class of synthetic antituberculosis agent in vitro and in vivo activities of DuP-721 against Mycobacterium tuberculosisDiagnostic Microbiology and Infectious Disease, 1991